Market Closed -
Other stock markets
|
Pre-market 07:08:24 am | |||
28.58 USD | -0.76% | 28.57 | -0.03% |
Jun. 08 | US FDA expands GSK's RSV vaccine approval to adults aged 50 to 59 | RE |
Jun. 07 | Pfizer's Paxlovid fails as 15-day treatment for long COVID, study finds | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.73% | 162B | |
+45.82% | 765B | |
-6.16% | 354B | |
+19.86% | 331B | |
+9.32% | 299B | |
+18.91% | 248B | |
-1.72% | 219B | |
+11.10% | 216B | |
+5.90% | 164B | |
-0.06% | 123B |
- Stock Market
- Equities
- PFE Stock
- News Pfizer, Inc.
- Pfizer, Genmab Say FDA Approves Tivak to Treat Cervical Cancer